...
首页> 外文期刊>Tropical Medicine and International Health: TM and IH >Operational feasibility of lot quality assurance sampling (LQAS) as a tool in routine process monitoring of filariasis control programmes.
【24h】

Operational feasibility of lot quality assurance sampling (LQAS) as a tool in routine process monitoring of filariasis control programmes.

机译:批量质量保证抽样(LQAS)在丝虫病控制程序的常规过程监控中的工具的运营可行性。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Lot quality assurance sampling (LQAS) with two-stage sampling plan was applied for rapid monitoring of coverage after every round of mass drug administration (MDA). A Primary Health Centre (PHC) consisting of 29 villages in Thiruvannamalai district, Tamil Nadu was selected as the study area. Two threshold levels of coverage were used: threshold A (maximum: 60%; minimum: 40%) and threshold B (maximum: 80%; minimum: 60%). Based on these thresholds, one sampling plan each for A and B was derived with the necessary sample size and the number of allowable defectives (i.e. defectives mean those who have not received the drug). Using data generated through simple random sampling (SRSI) of 1,750 individuals in the study area, LQAS was validated with the above two sampling plans for its diagnostic and field applicability. Simultaneously, a household survey (SRSH) was conducted for validation and cost-effectiveness analysis. Based on SRSH survey, the estimated coverage was 93.5% (CI: 91.7-95.3%). LQAS with threshold A revealed that by sampling a maximum of 14 individuals and by allowing four defectives, the coverage was >or=60% in >90% of villages at the first stage. Similarly, with threshold B by sampling a maximum of nine individuals and by allowing four defectives, the coverage was >or=80% in >90% of villages at the first stage. These analyses suggest that the sampling plan (14,4,52,25) of threshold A may be adopted in MDA to assess if a minimum coverage of 60% has been achieved. However, to achieve the goal of elimination, the sampling plan (9, 4, 42, 29) of threshold B can identify villages in which the coverage is <80% so that remedial measures can be taken. Cost-effectiveness analysis showed that both options of LQAS are more cost-effective than SRSH to detect a village with a given level of coverage. The cost per village was US dollars 76.18 under SRSH. The cost of LQAS was US dollars 65.81 and 55.63 per village for thresholds A and B respectively. The total financial cost of classifying a village correctly with the given threshold level of LQAS could be reduced by 14% and 26% of the cost of conventional SRSH method.
机译:每轮大规模药物管理(MDA)后,采用具有两阶段抽样计划的批次质量保证抽样(LQAS)来快速监测覆盖率。由泰米尔纳德邦Thiruvannamalai地区Thiruvannamalai地区的29个村庄组成的初级卫生中心(PHC)被选为研究区域。使用了两个阈值覆盖级别:阈值A(最大:60%;最小:40%)和阈值B(最大:80%;最小:60%)。根据这些阈值,得出一个针对A和B的抽样计划,其中包括必要的样本数量和允许的缺陷数量(即缺陷是指未收到药物的人)。利用研究区域内1,750名个体的简单随机抽样(SRSI)生成的数据,LQAS已通过上述两个抽样计划进行了验证,从而可用于其诊断和现场应用。同时,进行了住户调查(SRSH)以进行验证和成本效益分析。根据SRSH调查,估计覆盖率为93.5%(CI:91.7-95.3%)。具有阈值A的LQAS显示,在第一阶段,通过最多抽样14个人并允许四个缺陷,覆盖率在> 90%的村庄中大于或等于60%。类似地,在阈值B下,通过最多抽样九个人并允许四个缺陷,在第一阶段,覆盖率在> 90%的村庄中大于或等于80%。这些分析表明,可以在MDA中采用阈值A的抽样计划(14、4、52、25),以评估是否已达到60%的最低覆盖率。但是,为了达到消灭目标,阈值B的采样计划(9、4、42、29)可以识别覆盖率小于80%的村庄,从而可以采取补救措施。成本效益分析表明,LQAS的两种选择都比SRSH更具成本效益,以检测具有给定覆盖范围的村庄。根据SRSH,每个村庄的成本为76.18美元。阈值A和B的每个村庄的LQAS成本分别为65.81美元和55.63美元。在给定的LQAS阈值水平下,正确分类村庄的总财务成本可以降低传统SRSH方法成本的14%和26%。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号